These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29184391)

  • 1. Novel production method of innovative antiangiogenic and antitumor small peptides in
    Setrerrahmane S; Yu J; Hao J; Zheng H; Xu H
    Drug Des Devel Ther; 2017; 11():3207-3220. PubMed ID: 29184391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scalable Production of Recombinant Membrane Active Peptides and Its Potential as a Complementary Adjunct to Conventional Chemotherapeutics.
    Rothan HA; Ambikabothy J; Abdulrahman AY; Bahrani H; Golpich M; Amini E; A Rahman N; Teoh TC; Mohamed Z; Yusof R
    PLoS One; 2015; 10(9):e0139248. PubMed ID: 26418816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and purification of a recombinant ELRL-MAP30 with dual-targeting anti-tumor bioactivity.
    Chen WW; Zhang HR; Huang ZG; Zhou ZY; Lou QW; Jiang XY; Zhu ZH
    Protein Expr Purif; 2021 Sep; 185():105893. PubMed ID: 33933613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of novel benzylidene-succinimide derivatives as noncytotoxic antiangiogenic inhibitors with anticolorectal cancer activity in vivo.
    Luo K; Bao Y; Liu F; Xiao C; Li K; Zhang C; Huang R; Lin J; Zhang J; Jin Y
    Eur J Med Chem; 2019 Oct; 179():805-827. PubMed ID: 31295714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGFR2 Mimicking Peptide Inhibits the Proliferation of Human Umbilical Vein Endothelial Cells (Huvecs) by Blocking VEGF.
    Ghasemali S; Barzegar A; Farajnia S; Rahmati M; Negahdari B; Etemadi A; Nazari A
    Anticancer Agents Med Chem; 2023; 23(14):1678-1688. PubMed ID: 37194933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
    Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-Amino-2,4,5-trimethylpyridin-3-ols: a new general synthetic route and antiangiogenic activity.
    Kim DG; Kang Y; Lee H; Lee EK; Nam TG; Kim JA; Jeong BS
    Eur J Med Chem; 2014 May; 78():126-39. PubMed ID: 24681390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antiangiogenic activity of 6-amido-2,4,5-trimethylpyridin-3-ols.
    Lee H; Banskota S; Kim DG; Been JH; Jin YJ; Gautam J; Jang H; Nam TG; Kim JA; Jeong BS
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3131-6. PubMed ID: 24894557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of an Anticancer Fusion Peptide (ACFP) Derived from Milk Proteins and an Assay of Anti-ovarian Cancer Cells in vitro.
    Zhou J; Yang X; Zhang W; Wang J; Wei C; Gu F; Lei T; Qin Y
    Anticancer Agents Med Chem; 2017; 17(4):635-643. PubMed ID: 27357543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor peptide AP25 decreases cyclin D1 expression and inhibits MGC-803 proliferation via phospho-extracellular signal-regulated kinase-, Src-, c-Jun N-terminal kinase- and phosphoinositide 3-kinase-associated pathways.
    Hu J; Cheng T; Zhang L; Sun B; Deng L; Xu H
    Mol Med Rep; 2015 Sep; 12(3):4396-4402. PubMed ID: 26063313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antiangiogenic and antiproliferative potential of ethanolic extracts of
    Muralidharan K; Kumaravelu P; David DC
    J Cancer Res Ther; 2021; 17(2):484-490. PubMed ID: 34121696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyalomma dromedarii (Acari: Ixodidae) Salivary Gland Extract Inhibits Angiogenesis and Exhibits In Vitro Antitumor Effects.
    Bensaoud C; Abdelkafi-Koubaa Z; Ben Mabrouk H; Morjen M; Hmila I; Rhim A; Ayeb ME; Marrakchi N; Bouattour A; M'ghirbi Y
    J Med Entomol; 2017 Nov; 54(6):1476-1482. PubMed ID: 29029126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of in vivo anticancer and antiangiogenic potential of thalidomide derivatives.
    da Costa PM; da Costa MP; Carvalho AA; Cavalcanti SM; de Oliveira Cardoso MV; de Oliveira Filho GB; de Araújo Viana D; Fechine-Jamacaru FV; Leite AC; de Moraes MO; Pessoa C; Ferreira PM
    Chem Biol Interact; 2015 Sep; 239():174-83. PubMed ID: 26134001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma.
    Zhu Y; Yuan T; Zhang Y; Shi J; Bai L; Duan X; Tong R; Zhong L
    Drug Des Devel Ther; 2019; 13():4321-4330. PubMed ID: 31908417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of small molecules targeting GRP78 for antiangiogenic and anticancer therapy.
    Qiao Y; Dsouza C; Matthews AA; Jin Y; He W; Bao J; Jiang F; Chandna R; Ge R; Fu L
    Eur J Med Chem; 2020 May; 193():112228. PubMed ID: 32199134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periplasmic expression optimization of VEGFR2 D3 adopting response surface methodology: antiangiogenic activity study.
    Cao W; Li H; Zhang J; Li D; Acheampong DO; Chen Z; Wang M
    Protein Expr Purif; 2013 Aug; 90(2):55-66. PubMed ID: 23680780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth.
    Rosca EV; Lal B; Koskimaki JE; Popel AS; Laterra J
    Anticancer Drugs; 2012 Aug; 23(7):706-12. PubMed ID: 22495619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphenylurea/thiourea derivatives tagged with heteroarylsulfonamide motifs as novel VEGFR2 inhibitors; Design, synthesis and anti-angiogenic activity.
    Al-Ansary GH; Nasr T; Taha H; Fayad W; Mahgoub S
    Bioorg Chem; 2021 Feb; 107():104640. PubMed ID: 33485105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic Effect of Isomalyngamide A Riboside CY01 in Breast Cancer Cells
    Shih CY; Chang TT; Chen CL; Li WS
    Anticancer Agents Med Chem; 2020; 20(3):386-399. PubMed ID: 31629398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.